Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

G1 Therapeutics Q4 EPS $(0.21) Beats $(0.28) Estimate, Sales $14.87M Beat $13.08M Estimate

Author: Benzinga Newsdesk | February 28, 2024 07:38am
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.28) by 25 percent. This is a 71.23 percent increase over losses of $(0.73) per share from the same period last year. The company reported quarterly sales of $14.87 million which beat the analyst consensus estimate of $13.08 million by 13.72 percent. This is a 45.10 percent increase over sales of $10.25 million the same period last year.

Posted In: GTHX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist